Revenue

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
HIV Revenue	7.51B	7.09B
Respiratory, Immunology and Inflammation Revenue	3.63B	3.30B
Oncology Revenue	1.82B	1.41B
Specialty Medicines Revenue	12.97B	11.81B
Shingles Revenue	3.40B	3.36B
Meningitis Revenue	1.57B	1.44B
Influenza Revenue	328.00M	408.00M
Established Vaccines Revenue	3.23B	3.34B
Vaccines Revenue	9.08B	9.14B
Respiratory Revenue	7.09B	7.21B
Other General Medicines Revenue	3.03B	3.22B
General Medicines Revenue	10.12B	10.43B
Total Commerical Operations Revenue	32.17B	31.38B
Revenue (Total)	32.17B	31.38B

Revenue by Geography

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Commercial Operations Segment Profit	15.86B	15.34B
Research & Development Segment Profit	-6.10B	-5.85B
Operating Income (Other)	23.21B	-5.47B
Operating Income (Total)	32.98B	4.02B

Updated Sep 30, 2025. Data Source: Fiscal.ai.